Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short term Debt: 2018-2019

Historic Short term Debt for Sunshine Biopharma (SBFM) over the last 1 years, with Sep 2019 value amounting to $27,541.

  • Sunshine Biopharma's Short term Debt was N/A to $27,541 in Q3 2019 from the same period last year, while for Sep 2019 it was $27,541, marking a year-over-year change of. This contributed to the annual value of $20,871 for FY2018, which is N/A change from last year.
  • Latest data reveals that Sunshine Biopharma reported Short term Debt of $27,541 as of Q3 2019, which was down 1.18% from $27,869 recorded in Q2 2019.
  • Over the past 5 years, Sunshine Biopharma's Short term Debt peaked at $59,558 during Q1 2019, and registered a low of $20,871 during Q4 2018.
  • Its 2-year average for Short term Debt is $33,960, with a median of $27,705 in 2019.